Anne M. Hassell

4.2k citations

32 papers · 2.9k indexed · 1 hit paper · h-index 21

Molecular Biology top 5%
Oncology top 2%
Organic Chemistry top 5%
Cancer Research top 5%
Pulmonary and Respiratory Medicine top 10%

Co-authors: Lisa M. Shewchuk Steven R. Jordan Millard H. Lambert Michael Luther Byron Ellis William D. Holmes Edgar R. Wood Derek Yuan
Topics: Bone Metabolism and Diseases (7 papers)Protease and Inhibitor Mechanisms (6 papers)Natural product bioactivities and synthesis (4 papers)
Cited by: Oncology Cancer Research Molecular Biology
Journals: Nature Science Proceedings of the National Academy of Sciences
Partner nations: United States Netherlands United Kingdom

In The Last Decade

Anne M. Hassell

32 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Unique Structure for Epidermal Growth Factor Receptor Bound to GW572016 (Lapatinib)

2004 881 citations Edgar R. Wood, Anne T. Truesdale et al. Cancer Research profile →

Peers

Countries citing papers authored by Anne M. Hassell

Since Specialization

Citations

This map shows the geographic impact of Anne M. Hassell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne M. Hassell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne M. Hassell more than expected).

Fields of papers citing papers by Anne M. Hassell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne M. Hassell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne M. Hassell. The network helps show where Anne M. Hassell may publish in the future.

Co-authorship network of co-authors of Anne M. Hassell

This figure shows the co-authorship network connecting the top 25 collaborators of Anne M. Hassell. A scholar is included among the top collaborators of Anne M. Hassell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne M. Hassell. Anne M. Hassell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of 3,5-disubstituted-1H-pyrrolo[2,3-b]pyridines as potent inhibitors of the insulin-like growth factor-1 receptor (IGF-1R) tyrosine kinase 2009 ·Bioorganic & Medicinal Chemistry Letters ·Samarjit Patnaik,Kirk L. Stevens,(unknown),Felix Deanda,J. Brad Shotwell,Jun Tang,(unknown),Hiroko Nakamura,M. Anthony Leesnitzer,Anne M. Hassell,(unknown),Rakesh Kumar,Huangshu Lei,Stanley D. Chamberlain	20
2	Synthesis and evaluation of pyrazolo[1,5-b]pyridazines as selective cyclin dependent kinase inhibitors 2008 ·Bioorganic & Medicinal Chemistry Letters ·Kirk L. Stevens,Michael J. Reno,(unknown),Daniel J. Price,Laurie S. Kane-Carson,Victoria B. Knick,Lisa M. Shewchuk,Anne M. Hassell,James M. Veal,Stephen T. Davis,Robert Griffin,Michael Peel	26
3	Novel, potent P2–P3 pyrrolidine derivatives of ketoamide-based cathepsin K inhibitors 2006 ·Bioorganic & Medicinal Chemistry Letters ·David G. Barrett,John G. Catalano,David N. Deaton,Anne M. Hassell,Stacey T. Long,Aaron B. Miller,Larry R. Miller,John A. Ray,Vicente Sámano,Lisa M. Shewchuk,Kevin J. Wells‐Knecht,Derril H. Willard,Lois L. Wright	16
4	Crystallization of protein–ligand complexes 2006 ·Acta Crystallographica Section D Biological Crystallography ·Anne M. Hassell,Gang An,Randy K. Bledsoe,Jane M. Bynum,H. Luke Carter,Su-Jun Deng,Robert T. Gampe,(unknown),Kevin P. Madauss,Robert T. Nolte,Warren J. Rocque,Liping Wang,Kurt Weaver,Shawn P. Williams,G. Bruce Wisely,Robert X. Xu,Lisa M. Shewchuk	120
5	Novel and potent cyclic cyanamide-based cathepsin K inhibitors 2005 ·Bioorganic & Medicinal Chemistry Letters ·David N. Deaton,Anne M. Hassell,Robert B. McFadyen,Aaron B. Miller,Larry R. Miller,Lisa M. Shewchuk,Francis X. Tavares,Derril H. Willard,Lois L. Wright	31
6	Semicarbazone-based inhibitors of cathepsin K, are they prodrugs for aldehyde inhibitors? 2005 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),David G. Barrett,David N. Deaton,Robert T. Gampe,Anne M. Hassell,Stacey T. Long,Robert B. McFadyen,Aaron B. Miller,Larry R. Miller,(unknown),Lisa M. Shewchuk,Kevin J. Wells‐Knecht,Derril H. Willard,Lois L. Wright	12
7	Acyclic cyanamide-based inhibitors of cathepsin K 2005 ·Bioorganic & Medicinal Chemistry Letters ·David G. Barrett,David N. Deaton,Anne M. Hassell,Robert B. McFadyen,Aaron B. Miller,Larry R. Miller,(unknown),Lisa M. Shewchuk,Derril H. Willard,Lois L. Wright	24
8	A Unique Structure for Epidermal Growth Factor Receptor Bound to GW572016 (Lapatinib)breakdown → 2004 ·Cancer Research ·Edgar R. Wood,Anne T. Truesdale,Octerloney B. McDonald,Derek Yuan,Anne M. Hassell,Scott H. Dickerson,Byron Ellis,(unknown),(unknown),Karen Lackey,Krystal J. Alligood,David W. Rusnak,Tona M. Gilmer,Lisa M. Shewchuk	881
9	Potent and selective P2–P3 ketoamide inhibitors of cathepsin K with good pharmacokinetic properties via favorable P1′, P1, and/or P3 substitutions 2004 ·Bioorganic & Medicinal Chemistry Letters ·David G. Barrett,John G. Catalano,David N. Deaton,Anne M. Hassell,Stacey T. Long,Aaron B. Miller,Larry R. Miller,Lisa M. Shewchuk,Kevin J. Wells‐Knecht,Derril H. Willard,Lois L. Wright	24
10	Exploration of the P2–P3 SAR of aldehyde cathepsin K inhibitors 2004 ·Bioorganic & Medicinal Chemistry Letters ·Eric E. Boros,David N. Deaton,Anne M. Hassell,Robert B. McFadyen,Aaron B. Miller,Larry R. Miller,Margot G. Paulick,Lisa M. Shewchuk,James B. Thompson,Derril H. Willard,Lois L. Wright	27
11	Lipopolysaccharide down-regulates inducible nitric oxide synthase expression in swine heart in vivo 2003 ·Biochemical and Biophysical Research Communications ·Rubin I. Cohen,Anne M. Hassell,Xiaobing Ye,(unknown),Shu Fang Liu	10
12	Crystallization of native and selenomethionyl yeast orotidine 5′-phosphate decarboxylase 2000 ·Acta Crystallographica Section D Biological Crystallography ·Brian G. Miller,Anne M. Hassell,Michael V. Milburn,Steven A. Short	1
13	Structure of the Tie2 RTK Domain 2000 ·Structure ·Lisa M. Shewchuk,Anne M. Hassell,Byron Ellis,William D. Holmes,(unknown),(unknown),Sue H. Kadwell,David D. McKee,John T. Moore	113
14	Two distinct approaches to crystallization results-recording databases 1994 ·Acta Crystallographica Section D Biological Crystallography ·Anne M. Hassell,(unknown),(unknown),(unknown)	4
15	Structural Analysis of the Catalytic Domain of Human Fibroblast Collagenase 1994 ·Annals of the New York Academy of Sciences ·Brett Lovejoy,Anne Cleasby,Anne M. Hassell,Michael Luther,Debra Weigl,Gerard M. McGeehan,Millard H. Lambert,Steven R. Jordan	16
16	Preliminary X-ray diffraction studies of recombinant 19 kDa human fibroblast collagenase 1994 ·Journal of Molecular Biology ·Anne M. Hassell,Robert J. Anderegg,Debra Weigl,Michael V. Milburn,William Burkhart,(unknown),Pierre Graber,Timothy N. C. Wells,Michael Luther,Steven R. Jordan	6
17	A novel dimer configuration revealed by the crystal structure at 2.4 Å resolution of human interleukin-5 1993 ·Nature ·Michael V. Milburn,Anne M. Hassell,Millard H. Lambert,Steven R. Jordan,Amanda E. I. Proudfoot,Pierre Graber,Timothy N. C. Wells	201
18	Purification, characterisation and crystallisation of selenomethionyl recombinant human interleukin‐5 from Escherichia coli 1993 ·European Journal of Biochemistry ·Pierre Graber,Alain R. Bernard,Anne M. Hassell,Michael V. Milburn,Steven R. Jordan,Amanda E. I. Proudfoot,Dilniya Fattah,Timothy N. C. Wells	17
19	Crystallization and Preliminary X-ray Diffraction Studies of Recombinant Human Interleukin-5 1993 ·Journal of Molecular Biology ·Anne M. Hassell,Timothy N. C. Wells,Pierre Graber,Amanda E. I. Proudfoot,Robert J. Anderegg,William Burkhart,Steven R. Jordan,Michael V. Milburn	8
20	Proteolysis of an active site peptide of lactate dehydrogenase by human immunodeficiency virus type 1 protease 1992 ·Biochemistry ·Thaddeus A. Tomaszek,Michael L. Moore,James E. Strickler,(unknown),(unknown),Brian W. Metcalf,Anne M. Hassell,Geoffrey B. Dreyer,(unknown)	35

About Anne M. Hassell

Anne M. Hassell is a scholar working on Immunology and Allergy, Cancer Research and Virology, having authored 32 papers that have together received 2.9k indexed citations. Recurring topics across this work include Bone Metabolism and Diseases (7 papers), Protease and Inhibitor Mechanisms (6 papers) and Natural product bioactivities and synthesis (4 papers). The work is most often cited by research in Oncology (1.0k citations), Cancer Research (408 citations) and Molecular Biology (1.6k citations). Anne M. Hassell has collaborated with scholars based in United States, Netherlands and United Kingdom. Frequent co-authors include Lisa M. Shewchuk, Steven R. Jordan, Millard H. Lambert, Michael Luther, Byron Ellis, William D. Holmes, Edgar R. Wood, Derek Yuan, Scott H. Dickerson and Anne T. Truesdale. Their work appears in journals such as Nature, Science and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact